HSIL.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Specialties

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
HSIL.BOHemant Surgical Industries Ltd.	$418.10	-3.90%	$6.0B	—
ASARFI.BOAsarfi Hospital Ltd.	$185.25	-0.94%	$3.6B	—
BDH.BOBDH Industries Limited	$500.00	-1.01%	$2.9B	—
LYKALABS.BOLyka Labs Limited	$82.45	+1.97%	$2.9B	—
LYKALABS.NSLyka Labs Limited	$80.11	-1.40%	$2.9B	—
NURECA.BONureca Limited	$334.50	+2.61%	$3.3B	—
SANJIVIN.BOSanjivani Paranteral Limited.	$180.00	+1.52%	$2.2B	—

Source: Financial Modeling Prep · peers by sector/industry

Hemant Surgical Industries Ltd.

Hemant Surgical Industries Ltd. functions as a pharmaceutical enterprise, focusing on the import, production, and distribution of both surgical equipment and pharmaceutical items. Hanskumar Shamji Shah established the firm in 1985, and its primary operations are based in Mumbai, India.

www.hemantsurgical.com

Employees: 109
IPO / List date: Jun 5, 2023
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds HSIL.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in HSIL.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded HSIL.BO yet.